Stockreport

Cognition Therapeutics CEO Issues Letter to Shareholders [Yahoo! Finance]

Cognition Therapeutics, Inc.  (CGTX) 
PDF dementia with Lewy bodies (DLB) psychosis Fully funded $80 million Phase 2 START trial readout expected in the second half of 2027 PURCHASE, N.Y., March 31, 2026 (G [Read more]